Using highly variable warfarin dosing to identify patients at risk for adverse events

被引：0
作者：
Lyndonna Marrast
Mary Evans
Al Ozonoff
Lori E Henault
Adam J Rose
机构：
[1] Boston University School of Medicine,Department of Medicine
[2] Boston Medical Center,Biostatistics Section
[3] Children's Hospital of Boston,Center for Health Quality, Outcomes, and Economic Research
[4] Bedford VA Medical Center,undefined
来源：
Thrombosis Journal | / 9卷 / 1期
关键词：
anticoagulants; dose variability; medication therapy management; risk factors; warfarin.;
D O I：
10.1186/1477-9560-9-14
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 178 条
  • [41] Choi PT(undefined)undefined undefined undefined undefined-undefined
  • [42] Douketis JD(undefined)undefined undefined undefined undefined-undefined
  • [43] Rose AJ(undefined)undefined undefined undefined undefined-undefined
  • [44] Ozonoff A(undefined)undefined undefined undefined undefined-undefined
  • [45] Grant RW(undefined)undefined undefined undefined undefined-undefined
  • [46] Henault LE(undefined)undefined undefined undefined undefined-undefined
  • [47] Hylek EM(undefined)undefined undefined undefined undefined-undefined
  • [48] White HD(undefined)undefined undefined undefined undefined-undefined
  • [49] Gruber M(undefined)undefined undefined undefined undefined-undefined
  • [50] Feyzi J(undefined)undefined undefined undefined undefined-undefined
12345678910